COVID-19 News

July 2, 2020July 6, 2020

PROTXX, University of Alberta Collaborate to Develop Remote Healthcare Platform for MS Patients

COVID-19 News, Multiple Sclerosis News Today

The University of Alberta and PROTXX are collaborating to develop wearable sensors for people with multiple sclerosis (MS) and advance a remote healthcare platform that facilitates personalized care and reduces frequency of ... Read more

July 1, 2020July 2, 2020

Amylyx Completes Enrollment in PEGASUS Trial of AMX0035 for Alzheimer’s

Alzheimer's News Today, COVID-19 News

Amylyx Pharmaceuticals announced it has completed enrollment for the Phase 2 clinical trial of AMX0035 for treating Alzheimer’s disease. The placebo-controlled trial, PEGASUS (NCT03533257), will evaluate the compound’s safety and tolerability among ... Read more

July 1, 2020July 6, 2020

Assessing Risk of Severe COVID-19 in MS Patients

COVID-19 News, Multiple Sclerosis News Today

Exposure to disease-modifying therapies does not increase multiple sclerosis (MS) patients’ risk of developing a severe form of COVID-19, according to a registry-based study. However, MS patients who are older, obese, ... Read more

July 1, 2020July 1, 2020

1,066 Myeloma Patients Answer HealthTree Survey of COVID-19’s Effects

COVID-19 News, Myeloma Research News

Over some four weeks, 1,066 people with multiple myeloma took part in a survey sponsored by HealthTree to better understand how COVID-19 is affecting life for those with this blood cancer. The survey, ... Read more

June 30, 2020July 1, 2020

1st Progressive MS Patient Enrolled in Phase 2 Study of Temelimab

COVID-19 News, Multiple Sclerosis News Today

GeNeuro announced that a first progressive multiple sclerosis (MS) patient has enrolled in its Phase 2 trial assessing the safety and effectiveness of temelimab in people whose disease is progressing in the absence of relapses. ... Read more

June 30, 2020July 1, 2020

COVID-19 Source of Anxiety for Women With CF Children

COVID-19 News, Cystic Fibrosis News Today

Anxiety related to fears of COVID-19 infection was higher among mothers of children with cystic fibrosis (CF) than those of healthy children, although teenage patients themselves were less anxious than age-matched peers ... Read more

June 30, 2020June 30, 2020

Second Surgery May Aid Survival in Recurrent Ovarian Cancer, Study Finds

COVID-19 News, Ovarian Cancer News Today

Woman whose ovarian cancer returns more than six months after initial surgery and chemotherapy may benefit from a second surgery, but only if the entire tumor is removed during the procedure, ... Read more

June 30, 2020June 30, 2020

Immunovant Prepares to Launch Phase 3 Trial of IMVT-1401 in MG Patients

COVID-19 News, Myasthenia Gravis News

Immunovant is preparing to launch a Phase 3 trial of its investigational candidate IMVT-1401 in patients with myasthenia gravis (MG); it may lead to the treatment’s approval for this indication, pending ... Read more

June 29, 2020June 29, 2020

Investigational Agitation Treatment AXS-05 Named FDA Breakthrough Therapy

Alzheimer's News Today, COVID-19 News

The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to Axsome Therapeutics‘ AXS-05, an investigational oral therapy for the treatment of agitation in people with Alzheimer’s disease. ... Read more

June 29, 2020June 29, 2020

Ninlaro Maintenance Therapy Improves Survival in Patients Not Given ASCT, Trial Shows

COVID-19 News, Myeloma Research News

First-line maintenance therapy with Ninlaro (ixazomib) significantly delays disease progression or death in adults with multiple myeloma who had not been initially treated with an autologous stem cell transplant (ASCT), according to ... Read more

June 26, 2020June 26, 2020

Online Resource Center Informs MS Patients About Treatments, Adherence

COVID-19 News, Multiple Sclerosis News Today

MyHealthTeams and EMD Serono have teamed up to launch the Treatment and Adherence Resource Center, a new informational tool within the MyMSTeam social network for people living with multiple sclerosis (MS). ... Read more

June 26, 2020June 26, 2020

Oncopeptides Reports Positive Results from HORIZON Trial of Melflufen Combo

COVID-19 News, Myeloma Research News

The combination therapy of melflufen (melphalan flufenamide) and dexamethasone continues to be safe and to elicit deep and durable responses in hard-to-treat patients with relapsed or refractory multiple myeloma, top-line ... Read more

June 26, 2020June 26, 2020

Flare Risk Drops if Brensocatib Clears Key Protein from NCFBE Patient Sputum, Trial Finds

Bronchiectasis News Today, COVID-19 News

Adults with non-cystic fibrosis bronchiectasis (NCFBE) who were given brensocatib in a Phase 2 trial were 72% less likely to be at risk of an exacerbation if neutrophil elastase in their sputum fell to undetectable ... Read more

June 24, 2020June 24, 2020

Activities, Events Ready for June 28 – International PKU Day

COVID-19 News, Phenylketonuria News

Activities and events have been planned to raise public knowledge and understanding of phenylketonuria (PKU) on June 28 — International Phenylketonuria Day. Due to the ongoing COVID-19 pandemic, the day ... Read more

June 24, 2020

COVID-19: Your Weekly Roundup of Key Developments

COVID-19 News

EU and US announce separate strategies for vaccine development The U.S. Department of Health and Human Services recently released a fact sheet explaining the Operation Warp Speed program announced in ... Read more